SOPHiA GENETICS (SOPH) has released an update.
SOPHiA GENETICS has announced strategic leadership changes with Ross Muken promoted to President and George Cardoza appointed as the new Chief Financial Officer. Muken, who has been with the company since 2021, will now oversee global operations and strategic planning. Cardoza brings over 30 years of financial expertise in precision medicine, poised to strengthen SOPHiA GENETICS’ growth trajectory.
For further insights into SOPH stock, check out TipRanks’ Stock Analysis page.
